Journal of neuroendovascular therapy最新文献

{"title":"Complete Recanalization in Mechanical Thrombectomy Is Associated with Favorable Functional Outcome for M2 Occlusions.","authors":"Yu Sakai,&nbsp;Gakushi Yoshikawa,&nbsp;Satoshi Koizumi,&nbsp;Osamu Ishikawa,&nbsp;Akira Saito,&nbsp;Katsuya Sato","doi":"10.5797/jnet.oa.2022-0057","DOIUrl":"https://doi.org/10.5797/jnet.oa.2022-0057","url":null,"abstract":"<p><strong>Objective: </strong>There are insufficient coherent reports on mechanical thrombectomy (MT) for occlusion of the second segment of the middle cerebral artery (M2 occlusion) in a real-world clinical setting. We evaluated the efficacy and safety of MT for M2 occlusions and compared the primary thrombectomy strategies (stent retriever, aspiration catheter, and combined technique) to analyze factors predicting good functional outcomes.</p><p><strong>Methods: </strong>We evaluated background factors, preprocedural factors, procedural factors, and procedural time for patients who underwent MT for M2 occlusions from our retrospective cohort. According to the modified Rankin Scale (mRS) score three months after MT, patients were divided into good (mRS ≤2) and poor (mRS ≥3) prognosis groups.</p><p><strong>Results: </strong>A total of 29 patients (median age, 78 years; 11 [37.9%] females) were included in the study. In this cohort, rates of successful reperfusion, thrombolysis in cerebral infarction (TICI) 3, postprocedural hemorrhage (PPH), and symptomatic PPH were 82.8, 34.5, 31.0, and 0%, respectively. Good prognoses were achieved in 13 (45%) cases. A prognostic factor of MT for M2 occlusions is TICI 3 from multivariate analysis (OR, 11.7; 95% CI, 1.003-136; p = 0.0497). There was no statistically significant difference in the functional outcome three months after MT based on the choice of the primary thrombectomy strategy.</p><p><strong>Conclusion: </strong>MT for M2 occlusions is a reliable and relatively safe procedure. The presence of TICI 3 was a prognostic factor in this cohort. Future studies are warranted to investigate the optimal thrombectomy strategy for medium vessel occlusion.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"17 1","pages":"15-21"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/74/77/jnet-17-15.PMC10370515.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10263238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Analysis of Cerebrovascular Events after Coil Embolization of Unruptured Cerebral Aneurysms in Patients Taking Anticoagulants.","authors":"Hayatsura Hanada,&nbsp;Kouhei Nii,&nbsp;Kimiya Sakamoto,&nbsp;Ritsurou Inoue,&nbsp;Yoko Hirata,&nbsp;Kodai Matsuda,&nbsp;Jun Tsugawa,&nbsp;Sho Takeshita,&nbsp;Sachiko Shirakawa,&nbsp;Toshio Higashi","doi":"10.5797/jnet.oa.2022-0061","DOIUrl":"https://doi.org/10.5797/jnet.oa.2022-0061","url":null,"abstract":"<p><strong>Objective: </strong>Antiplatelet therapy is advised to prevent thrombotic complications during endovascular coil embolization of unruptured cerebral aneurysms. Due to multiple antithrombotic treatments, bleeding risk is a concern in patients using oral anticoagulants for existing comorbidities. We investigated the hemorrhagic and ischemic events following endovascular treatment (EVT) of unruptured cerebral aneurysms in patients taking anticoagulation and antiplatelet therapy.</p><p><strong>Methods: </strong>Between March 2013 and February 2019, 262 patients undergoing EVT for unruptured cerebral aneurysms and having at least 6 months of postoperative follow-up data were included in this retrospective study. Patients taking oral anticoagulants and antiplatelet drugs for cerebral vascular events following EVT were compared with those taking only antiplatelet agents.</p><p><strong>Results: </strong>Of the 262 patients, 12 (4.6%) used anticoagulants before EVT for a preexisting condition. Cerebrovascular events after coil embolization were observed in 3 patients taking both anticoagulant and antiplatelet drugs and in 14 patients taking only antiplatelet drugs (25% vs. 5.6%, respectively, p = 0.035). Vitamin K antagonist (VKA) was administered in five patients and direct oral anticoagulants (DOACs) in seven patients. Patients taking VKA experienced cerebrovascular events, whereas those taking DOACs did not (p = 0.045).</p><p><strong>Conclusion: </strong>Our study showed that patients using oral anticoagulants and antiplatelet drugs experienced more cerebrovascular events after EVT for unruptured cerebral aneurysms. These results suggest that in patients requiring oral anticoagulants, DOACs may be more beneficial than VKA for preventing stroke occurrences after EVT.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"17 3","pages":"73-79"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/39/94/jnet-17-73.PMC10370510.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10245763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Predictors of Outcomes Six Months after Endovascular Coil Embolization of Poor-Grade Aneurysmal Subarachnoid Hemorrhage.","authors":"Taisuke Akimoto,&nbsp;Makoto Ohtake,&nbsp;Takafumi Kawasaki,&nbsp;Shuto Fushimi,&nbsp;Wataru Shimohigoshi,&nbsp;Hiroshi Manaka,&nbsp;Takashi Kawasaki,&nbsp;Katsumi Sakata,&nbsp;Ichiro Takeuchi,&nbsp;Tetsuya Yamamoto","doi":"10.5797/jnet.oa.2022-0043","DOIUrl":"https://doi.org/10.5797/jnet.oa.2022-0043","url":null,"abstract":"<p><strong>Objective: </strong>To identify factors associated with the outcome and prognosis of coil embolization for poor-grade aneurysmal subarachnoid hemorrhage (aSAH).</p><p><strong>Methods: </strong>We retrospectively reviewed 118 patients with World Federation of Neurosurgical Societies (WFNS) grade IV or V subarachnoid hemorrhage at our institute between January 2010 and December 2020. Outcomes were assessed using modified Rankin Scale (mRS) scores at discharge and at six months after aSAH onset. In addition, patient background, aneurysm characteristics, and treatment outcome were compared between patients showing favorable (mRS scores: 0-2) and unfavorable (mRS scores: 3-6) outcomes at six months. Factors for change of mRS during follow-up were explored, and cut off values were calculated for age using the receiver operating characteristic analysis.</p><p><strong>Results: </strong>Endovascular treatment was performed in 51 of the 118 enrolled patients. Data were analyzed for 43 of these patients who underwent coil embolization of ruptured aneurysms and had complete datasets. The mean age was 61.7 years and 24 (55.8%) patients had WFNS grade V aSAH. Coil embolization-related complications were observed in three patients. There were no treatment-related deaths; however, eight patients (18.6%) died at three months. Multivariate analysis showed that the maximum diameter of the aneurysm (p=0.041) and the postoperative dual antiplatelet therapy (DAPT) (p=0.040) were associated with unfavorable and favorable outcomes, respectively. Older age (p=0.033) was independently associated with mRS score deterioration following discharge. Age 72 years and older was the cut off value for mRS deterioration.</p><p><strong>Conclusion: </strong>Aneurysm size and postoperative DAPT might be associated with outcomes at 6 months. Moreover, we identified older age as an independent factor that influences mRS deterioration following discharge; thus, especially in cases of elderly patients over 72 years of age, it is highly likely that long-term care to prevent disuse and regular follow-up on imaging will be necessary.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"17 2","pages":"47-55"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fc/ce/jnet-17-47.PMC10370525.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9884479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Predictive Value of Acute Neurological Progression Using Bayesian CT Perfusion for Acute Ischemic Stroke with Large or Median Vessel Occlusion.","authors":"Shinya Yoshii, Satoshi Fujita, Yu Hiramoto, Morito Hayashi, Satoshi Iwabuchi","doi":"10.5797/jnet.oa.2023-0046","DOIUrl":"10.5797/jnet.oa.2023-0046","url":null,"abstract":"<p><strong>Objective: </strong>Since the efficacy of mechanical thrombectomy (MT) for acute cerebral infarction due to large vessel occlusion has been proven, the time available for treatment has gradually increased. Currently, under certain conditions, treatment is indicated up to 24 h from onset. Based on neurological signs and imaging diagnosis, Stroke Treatment Guideline 2021 recommends initiation of MT within 6-24 h from onset. Herein, we retrospectively investigated the relationship between cerebral perfusion imaging evaluation and prognosis in patients with acute cerebral infarction due to large or median vessel occlusion.</p><p><strong>Methods: </strong>Fifty-one patients diagnosed with acute cerebral infarction due to large or median vessel occlusions in anterior circulation between November 2019 and December 2021 were divided into medical care and reconstructive therapy (including tissue plasminogen activator [t-PA] therapy and MT) groups. The primary outcome was changes in the National Institutes of Health Stroke Scale (NIHSS) at admission and 1 week after onset. Patients in the medical care group were divided into those whose NIHSS did not worsen and those whose NIHSS worsened. Those in the reconstructive therapy group were divided into those whose NIHSS improved and those whose NIHSS did not improve. We evaluated the relationship between improvement factors in acute neurological symptoms and penumbral and core volumes from computed tomography perfusion performed at admission.</p><p><strong>Results: </strong>Of 45 eligible patients, 10 received medical care without t-PA or MT and 35 underwent reconstructive therapy, including t-PA and MT. Among the 10 patients in the medical care group, 3 had worsening symptoms and 7 did not. The mean and median (interquartile range [IQR]) penumbra volumes were significantly higher in patients with worsening symptoms than in those without. The receiver operating characteristic (ROC) curve showed a threshold value of 28.6 mL with an area under the curve (AUC) of 0.952. Among the 35 patients in the reconstructive therapy group, symptoms improved for 29 but did not improve for 6. The mean and median (IQR) core volumes were significantly higher in patients whose symptoms did not improve than in those whose symptoms improved. The ROC curve showed a threshold value of 25 mL and an AUC of 0.632.</p><p><strong>Conclusion: </strong>Evaluation of penumbra volumes could detect cases with worsening symptoms in cases where medical care was performed, and evaluation of core volumes may detect cases with non-improved symptoms in cases that received reconstructive therapy.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 1","pages":"1-9"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10800166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139520543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Questionnaire Survey of Neurointerventional Simulation Training in the Japanese Society for Neuroendovascular Therapy.","authors":"Yuki Ebisudani,&nbsp;Kenji Sugiu,&nbsp;Satoshi Murai,&nbsp;Jun Haruma,&nbsp;Masafumi Hiramatsu,&nbsp;Tomohito Hishikawa,&nbsp;Isao Date","doi":"10.5797/jnet.ra.2022-0062","DOIUrl":"https://doi.org/10.5797/jnet.ra.2022-0062","url":null,"abstract":"<p><strong>Objective: </strong>Simulation training has focused on education and practical training. However, the adoption rate of neurointerventional simulation training in Japan is unknown. Therefore, we sent a questionnaire survey form to consulting specialists from the Japanese Society for Neuroendovascular Therapy (JSNET) to clarify the actual simulation training situation and compare the differences between university hospitals and general hospitals in Japan.</p><p><strong>Methods: </strong>The questionnaire survey was conducted in 243 neurosurgical training facilities that had JSNET consulting specialists between May 31, 2021 and July 31, 2021. The questionnaire survey forms were distributed by Google Forms.</p><p><strong>Results: </strong>A total of 162 facilities responded to the survey (response rate: 66.7%; 35.2% from university hospitals and 64.8% from general hospitals). The adoption rate for simulation training was 53.7%, and it was significantly higher in the university hospitals than in the general hospitals (64.9% vs. 47.6%, <i>p</i> = 0.035). On the simulation effectiveness survey, more than 80% of respondents answered that the simulation training was a useful tool for upskill training. The open-ended question on interventional simulation training showed that there are limiting factors such as financial constraints. Additionally, respondents expressed a desire for a standard neurointerventional simulation training and education program.</p><p><strong>Conclusion: </strong>The adoption rate for simulation training was 53.7% in the training facilities of JSNET, and it was higher in the university hospitals than in the general hospitals. Most of the respondents answered that simulation training is an effective tool to improve neurointerventional skills. They also requested the establishment of simulation training programs and simulation tools.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"17 9","pages":"181-187"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/51/2e/jnet-17-181.PMC10508991.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41161776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of Access Route for Endovascular Treatment by Time-Spatial Labeling Inversion Pulse (Time-SLIP) MRA and Contrast-Enhanced MRA.","authors":"Satoshi Kobayashi,&nbsp;Toshiya Osanai,&nbsp;Taku Sugiyama,&nbsp;Noriyuki Fujima,&nbsp;Ryo Takagi,&nbsp;Isao Yokota,&nbsp;Akiyoshi Hamaguchi,&nbsp;Toshitaka Nakamura,&nbsp;Kazutoshi Hida,&nbsp;Miki Fujimura","doi":"10.5797/jnet.oa.2023-0001","DOIUrl":"https://doi.org/10.5797/jnet.oa.2023-0001","url":null,"abstract":"<p><strong>Objective: </strong>In endovascular treatment, it is important to evaluate the access route for placing a catheter into the common carotid artery (CCA) promptly and safely prior to the procedure. We examined whether non-contrast MRA using time-spatial labeling inversion pulse (Time-SLIP) can be used in patients prior to endovascular thrombectomy for acute ischemic stroke. We compared Time-SLIP MRA to contrast-enhanced (CE) MRA and evaluated the efficacy in the evaluation of access routes.</p><p><strong>Methods: </strong>We retrospectively reviewed 31 patients admitted between October 2018 and December 2018 for cerebral infarction at our hospital. Blood vessels were imaged from the aortic arch to the CCA. A radiologist blindly evaluated quality score, stenosis, shape of the aorta, and degree of tortuosity.</p><p><strong>Results: </strong>There were no \"non-diagnostic\" images. The sensitivity, specificity, positive predictive value, and negative predictive value for stenosis were 83%, 96%, 83%, and 96%, respectively. The sensitivity for the aorta type classification was 100%. The sensitivity for mild tortuosity was 93%, for moderate was 100%, and for severe was 100%.</p><p><strong>Conclusion: </strong>Time-SLIP MRA can be an alternative to CE MRA in access route assessment for patients with cerebral infarction who are not eligible for acute thrombectomy therapy.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"17 6","pages":"120-124"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c6/4e/jnet-17-120.PMC10400895.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9953340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Case of Cerebral Hyperperfusion Syndrome during Treatment of Transient Cerebral Vasospasm Following Carotid Artery Stenting.","authors":"Motoshige Yamashina, Yohei Sato, Mariko Noda, Mayu Sasakawa, Thiparpa Thamamongood, Akihiro Hashizume, Takahiro Ogishima, Masashi Tamaki","doi":"10.5797/jnet.cr.2022-0065","DOIUrl":"10.5797/jnet.cr.2022-0065","url":null,"abstract":"<p><strong>Objective: </strong>We report a case in which transient cerebral vasospasm after carotid artery stenting (CAS) was effectively treated using arterial and intravenous infusion of fasudil hydrochloride, but cerebral hyperperfusion syndrome (CHS) developed during subsequent treatment.</p><p><strong>Case presentation: </strong>The patient was a 79-year-old man who underwent right CAS to treat symptomatic right carotid artery stenosis. After the procedure, the patient developed left paresis and unilateral spatial neglect. The following day, he developed diffuse cerebral vasospasm in the right middle cerebral artery that improved immediately upon arterial infusion of fasudil hydrochloride. Intravenous infusion of fasudil hydrochloride was then started, but CHS with epileptic seizures developed after 1 day of treatment. After 23 days of medical treatment, the condition of the patient improved to mild hemiparesis.</p><p><strong>Conclusion: </strong>The present case suggests that transient cerebral vasospasm after CAS may turn into CHS during treatment and that continuous monitoring for cerebral perfusion is important.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"17 3","pages":"80-87"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a7/2d/jnet-17-80.PMC10370509.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10245768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Case of Dural Arteriovenous Fistula Following Cerebral Venous Sinus Thrombosis Associated with the COVID-19 Vaccine.","authors":"Jiro Aoyama, Hiroto Iha, Mariko Ishikawa, Hirotaka Sagawa, Sakyo Hirai, Kyohei Fujita, Shoko Fujii, Kazutaka Sumita","doi":"10.5797/jnet.cr.2023-0052","DOIUrl":"10.5797/jnet.cr.2023-0052","url":null,"abstract":"<p><strong>Objective: </strong>Cerebral venous sinus thrombosis (CVST) is one of the rare and severe complications of coronavirus disease 2019 (COVID-19) vaccines. CVST has also been reported to develop into dural arteriovenous fistula; however, there were no reports of dural arteriovenous fistula associated with COVID-19 vaccine-induced cerebral venous sinus thrombosis. Here, we describe a rare case of a transverse-sigmoid sinus dural arteriovenous fistula followed by CVST due to COVID-19 vaccination.</p><p><strong>Case presentation: </strong>A 70-year-old patient presented with headache five days after receiving a second dose of COVID-19 vaccine. MRI showed a CVST in the superior sagittal sinus, left transverse sinus, and left sigmoid sinus. His headache improved after the administration of anticoagulant therapy. Six months later, a similar headache recurred, and cerebral angiography demonstrated a dural arteriovenous fistula in the left transverse sigmoid sinus and convexity dural arteriovenous fistulas in the left parietal cortex. The patient was treated twice with two sessions of transarterial embolization, and the shunts were completely occluded. His symptoms improved, and he was discharged with a modified Rankin Scale score of 0.</p><p><strong>Conclusion: </strong>Dural arteriovenous fistula can develop after CVST in association with COVID-19 vaccination.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 1","pages":"24-28"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10800167/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139520289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Case of Cavernous Sinus Dural Arteriovenous Fistula Draining Solely to the Superior Ophthalmic Vein with Normal Cerebral Venous Flow from the Superficial Middle Cerebral Vein to the Inferior Petrosal Sinus due to a Septum in the Cavernous Sinus.","authors":"Yushin Takemoto,&nbsp;Yuki Ohmori,&nbsp;Yasuyuki Kaku,&nbsp;Akitake Mukasa,&nbsp;Hiro Kiyosue","doi":"10.5797/jnet.cr.2023-0015","DOIUrl":"https://doi.org/10.5797/jnet.cr.2023-0015","url":null,"abstract":"<p><strong>Objective: </strong>We report here an atypical case of cavernous sinus dural arteriovenous fistula (CSDAVF) with a septation that separates the cavernous sinus (CS) into two components, namely, normal cerebral venous drainage and shunted blood drainage into the superior ophthalmic vein (SOV) alone. The CSDAVF was successfully treated by selective transvenous embolization (TVE) through the septum with the trans-inferior petrosal sinus (IPS) approach.</p><p><strong>Case presentation: </strong>A 74-year-old woman presented with right exophthalmos and tinnitus on the right side. Neuroradiological examination showed CSDAVF mainly supplied by multiple feeders from the bilateral ascending pharyngeal artery and meningohypophyseal trunk with a shunted pouch located medial-dorsally to the right CS. Blood from the CSDAVF drained via the anterior component of the CS to the right SOV only. Normal cerebral venous blood from the right superficial middle cerebral vein drained through the dorsolateral component of the right CS into the right IPS. These findings suggest that a septal barrier exists between the outflow tract of the dural arteriovenous fistula and the normal cerebral venous outflow tract within the CS. The CSDAVF was successfully treated by selective TVE through the septum with the trans-IPS approach after detailed evaluation of 3D rotational angiography (3DRA) and MRA/MR venography (MRV) cross-sectional images. The patient's symptoms improved, and she was discharged uneventfully.</p><p><strong>Conclusion: </strong>Septation within the CS can completely separate the drainage route of the CSDAVF from the normal cerebral drainage route. Successful catheterization to the shunted pouch through the septum with the IPS approach and selective embolization were possible with detailed evaluation of anatomy on MRA/MRV cross-sectional images and 3DRA images.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"17 7","pages":"145-152"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/10/52/jnet-17-145.PMC10400908.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10308777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Subacute In-Stent Occlusion 2 Weeks after CASPER Rx Stenting: A Case Report.","authors":"Eitaro Okumura,&nbsp;Sho Onodera,&nbsp;Hiroyuki Jimbo","doi":"10.5797/jnet.cr.2023-0009","DOIUrl":"https://doi.org/10.5797/jnet.cr.2023-0009","url":null,"abstract":"<p><strong>Objective: </strong>CASPER Rx stent (Terumo, Tokyo, Japan) is one of the dual-layer micromesh stents for carotid artery stenosis. Although it is expected to be safe and efficacious even for vulnerable plaque, we report a case of in-stent occlusion 2 weeks after stenting with CASPER Rx stent.</p><p><strong>Case presentation: </strong>The patient was a 78-year-old man with a symptomatic, severely stenosed lesion of the cervical internal carotid artery (ICA). He had an unstable plaque and underwent carotid artery stenting with the CASPER Rx stent. There were no problems with the procedure or the patient's subsequent course, and he was discharged home 1 week after the procedure. However, on postoperative day 14, the patient had a transit ischemic attack and imaging showed acute occlusion due to thrombus in the stent and in the distal part of the ICA. Mechanical thrombectomy was performed and good recanalization was achieved, but postoperative cerebral infarction was observed and the patient was transferred to other hospital with modified Rankin Scale 2.</p><p><strong>Conclusion: </strong>We experienced a case of in-stent occlusion 2 weeks after stenting with the CASPER Rx stent.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"17 8","pages":"173-179"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/62/4f/jnet-17-173.PMC10442173.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10058490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}